Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

计划入组 58 人 · 首次发布于 2019 年 9 月 4 日

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

计划入组 26 人 · 首次发布于 2012 年 2 月 13 日

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

计划入组 20 人 · 首次发布于 2009 年 3 月 20 日

Shigella vaccine

IVT-Shigella

Shigella-ETEC

SPECIAL CARE HOSPITAL

Saudi Arabia

Claudia Spies

Germany

XINING　SPECIAL　STEEL　CO.,LTD

Oral Shigella Vaccine Candidate WRSs2 Demonstrates 89% Efficacy in Phase 2 Controlled Human Infection Trial

Immuron Secures US Department of Defense Award for Novel Oral Therapeutics Against Military-Priority Pathogens

WHO Prioritizes Pathogens for Urgent Vaccine Development